Fine-tuning of the RIG-I-like receptor/interferon regulatory factor 3-dependent antiviral innate immune response by the glycogen synthase kinase 3/ß-catenin pathway

Molecular and Cellular Biology

Volumn 35, Issue 17, 2015, Pages 3029-3043

  Khan, Kashif Aziz ^a,d   Dô, Florence ^a   Marineau, Alexandre ^a   Doyon, Priscilla ^a   Clément, Jean François ^a   Woodgett, James R ^b   Doble, Bradley W ^c   Servant, Marc J ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; ANTIVIRUS AGENT; BETA CATENIN; BETA INTERFERON; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; RECEPTOR; RIG I LIKE RECEPTOR; UNCLASSIFIED DRUG; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA; INTERFERON; IRF3 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; EXON; FIBROBLAST; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SENDAI VIRUS INFECTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; GENETICS; HEK293 CELL LINE; HELA CELL LINE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; RESPIROVIRUS INFECTION; RHABDOVIRUS INFECTION; RNA INTERFERENCE; SENDAI VIRUS; TUMOR CELL LINE; VESICULAR STOMATITIS INDIANA VIRUS;

SENDAI VIRUS;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RESPIROVIRUS INFECTIONS; RHABDOVIRIDAE INFECTIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SENDAI VIRUS; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 84938851851     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00344-15     Document Type: Article

References (85)

1. Iwasaki A. 2012. A virological view of innate immune recognition. Annu Rev Microbiol 66:177-196. http://dx.doi.org/10.1146/annurev-micro-092611-150203.
2. Unterholzner L. 2013. The interferon response to intracellular DNA: why so many receptors? Immunobiology 218:1312-1321. http://dx.doi.org/10.1016/j.imbio.2013.07.007.
3. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20:4-22. http://dx.doi.org/10.1002/rmv.633.
4. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496. http://dx.doi.org/10.1038/ni921.
5. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
6. Suhara W, Yoneyama M, Kitabayashi I, Fujita T. 2002. Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J Biol Chem 277:22304-22313. http://dx.doi.org/10.1074/jbc.M200192200.
7. Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, Cao X. 2010. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 11:487-494. http://dx.doi.org/10.1038/ni.1876.
8. Zhu J, Coyne CB, Sarkar SN. 2011. PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and beta-catenin. EMBO J 30:4838-4849. http://dx.doi.org/10.1038/emboj.2011.351.
9. Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Wetzel JL, Sen GC. 2013. Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators. mBio 4(2):e00636-12.
10. Hiscott J, Grandvaux N, Sharma S, Tenoever BR, Servant MJ, Lin R. 2003. Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann N Y Acad Sci 1010:237-248. http://dx.doi.org/10.1196/annals.1299.042.
11. Servant MJ, Grandvaux N, tenOever BR, Duguay D, Lin R, Hiscott J. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J Biol Chem 278:9441-9447. http://dx.doi.org/10.1074/jbc.M209851200.
12. Woodgett JR. 1990. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431-2438.
13. Kaidanovich-Beilin O, Woodgett JR. 2011. GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci 4:40.
14. Sutherland C. 2011. What are the bona fide GSK3 substrates? Int J Alzheimers Dis 2011:505607.
15. Stamos JL, Weis WI. 2013. The beta-catenin destruction complex. Cold Spring Harb Perspect Biol 5:a007898. http://dx.doi.org/10.1101/cshperspect.a007898.
16. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. 2002. Control of beta-catenin phosphorylation/degradation by a dualkinase mechanism. Cell 108:837-847. http://dx.doi.org/10.1016/S0092-8674(02)00685-2.
17. Mbom BC, Nelson WJ, Barth A. 2013. ß-Catenin at the centrosome: discrete pools of ß-catenin communicate during mitosis and may coordinate centrosome functions and cell cycle progression. Bioessays 35:804-809. http://dx.doi.org/10.1002/bies.201300045.
18. Valenta T, Hausmann G, Basler K. 2012. The many faces and functions of ß-catenin. EMBO J 31:2714-2736. http://dx.doi.org/10.1038/emboj.2012.150.
19. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR. 2007. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/betacatenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 12:957-971. http://dx.doi.org/10.1016/j.devcel.2007.04.001.
20. Zeng X, Huang H, Tamai K, Zhang X, Harada Y, Yokota C, Almeida K, Wang J, Doble B, Woodgett J, Wynshaw-Boris A, Hsieh JC, He X. 2008. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135:367-375.
21. Itoh S, Saito T, Hirata M, Ushita M, Ikeda T, Woodgett JR, Algul H, Schmid RM, Chung UI, Kawaguchi H. 2012. GSK-3alpha and GSK-3beta proteins are involved in early stages of chondrocyte differentiation with functional redundancy through RelA protein phosphorylation. J Biol Chem 287:29227-29236. http://dx.doi.org/10.1074/jbc.M112.372086.
22. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML. 2008. Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455:1205-1209. http://dx.doi.org/10.1038/nature07284.
23. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NFkappaB activation. Nature 406:86-90. http://dx.doi.org/10.1038/35017574.
24. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C, Greytak S, Woulfe K, Trivedi CM, Woodgett JR, Epstein JA, Force T, Huggins GS. 2008. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 118:3609-3618. http://dx.doi.org/10.1172/JCI36245.
25. MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, Nagy A, Woodgett JR. 2007. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab 6:329-337. http://dx.doi.org/10.1016/j.cmet.2007.08.013.
26. Cheng H, Woodgett J, Maamari M, Force T. 2011. Targeting GSK-3 family members in the heart: a very sharp double-edged sword. J Mol Cell Cardiol 51:607-613. http://dx.doi.org/10.1016/j.yjmcc.2010.11.020.
27. Patel S, Doble BW, MacAulay K, Sinclair EM, Drucker DJ, Woodgett JR. 2008. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action. Mol Cell Biol 28:6314-6328. http://dx.doi.org/10.1128/MCB.00763-08.
28. Force T, Woodgett JR. 2009. Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem 284:9643-9647. http://dx.doi.org/10.1074/jbc.R800077200.
29. Woodgett JR. 2012. Can a two-faced kinase be exploited for osteosarcoma? J Natl Cancer Inst 104:722-723. http://dx.doi.org/10.1093/jnci/djs223.
30. Martin M, Rehani K, Jope RS, Michalek SM. 2005. Toll-like receptormediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6:777-784. http://dx.doi.org/10.1038/ni1221.
31. Beurel E, Michalek SM, Jope RS. 2010. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31:24-31. http://dx.doi.org/10.1016/j.it.2009.09.007.
32. Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, Mitchell T, Martin M. 2008. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J Immunol 181:6797-6802. http://dx.doi.org/10.4049/jimmunol.181.10.6797.
33. Wang JT, Chang LS, Chen CJ, Doong SL, Chang CW, Chen MR. 2014. Glycogen synthase kinase 3 negatively regulates IFN regulatory factor 3 transactivation through phosphorylation at its linker region. Innate Immun 20:78-87. http://dx.doi.org/10.1177/1753425913485307.
34. Lei CQ, Zhong B, Zhang Y, Zhang J, Wang S, Shu HB. 2010. Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33:878-889. http://dx.doi.org/10.1016/j.immuni.2010.11.021.
35. van Zuylen WJ, Doyon P, Clément JF, Khan KA, D'Ambrosio LM, Do F, St-Amant-Verret M, Wissanji T, Emery G, Gingras AC, Meloche S, Servant MJ. 2012. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity. PLoS Pathog 8:e1002747. http://dx.doi.org/10.1371/journal.ppat.1002747.
36. Kelly KF, Ng DY, Jayakumaran G, Wood GA, Koide H, Doble BW. 2011. ß-Catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism. Cell Stem Cell 8:214-227. http://dx.doi.org/10.1016/j.stem.2010.12.010.
37. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471.
38. Baril M, Es-Saad S, Chatel-Chaix L, Fink K, Pham T, Raymond VA, Audette K, Guenier AS, Duchaine J, Servant M, Bilodeau M, Cohen E, Grandvaux N, Lamarre D. 2013. Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog 9:e1003416. http://dx.doi.org/10.1371/journal.ppat.1003416.
39. Khan KA, Coaquette A, Davrinche C, Herbein G. 2009. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages. J Immunol 182:7784-7794. http://dx.doi.org/10.4049/jimmunol.0803800.
40. Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-642. http://dx.doi.org/10.1016/j.immuni.2006.04.004.
41. Gravel SP, Servant MJ. 2005. Roles of an IkappaB kinase-related pathway in human cytomegalovirus-infected vascular smooth muscle cells: a molecular link in pathogen-induced proatherosclerotic conditions. J Biol Chem 280:7477-7486. http://dx.doi.org/10.1074/jbc.M410392200.
42. Preston CM, Harman AN, Nicholl MJ. 2001. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 75:8909-8916. http://dx.doi.org/10.1128/JVI.75.19.8909-8916.2001.
43. Gaillard C, Strauss F. 1990. Ethanol precipitation of DNA with linear polyacrylamide as carrier. Nucleic Acids Res 18:378. http://dx.doi.org/10.1093/nar/18.2.378.
44. Andersen J, VanScoy S, Cheng TF, Gomez D, Reich NC. 2008. IRF-3-dependent and augmented target genes during viral infection. Genes Immun 9:168-175. http://dx.doi.org/10.1038/sj.gene.6364449.
45. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668-681. http://dx.doi.org/10.1016/j.cell.2010.04.018.
46. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76:5532-5539. http://dx.doi.org/10.1128/JVI.76.11.5532-5539.2002.
47. Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275. http://dx.doi.org/10.1016/S1535-6108(03)00241-1.
48. Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, Leost M, Ryan XP, Vonica CA, Brivanlou A, Dajani R, Crovace C, Tarricone C, Musacchio A, Roe SM, Pearl L, Greengard P. 2003. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 10:1255-1266. http://dx.doi.org/10.1016/j.chembiol.2003.11.010.
49. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297-315. http://dx.doi.org/10.1042/BJ20070797.
50. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789-799. http://dx.doi.org/10.1016/S0092-8674(00)81925-X.
51. Buescher JL, Phiel CJ. 2010. A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity. J Biol Chem 285:7957-7963. http://dx.doi.org/10.1074/jbc.M109.091603.
52. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986-2996.
53. Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. 2008. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J 27:2135-2146. http://dx.doi.org/10.1038/emboj.2008.126.
54. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. 1999. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18:5931-5942. http://dx.doi.org/10.1093/emboj/18.21.5931.
55. Wrobel CN, Mutch CA, Swaminathan S, Taketo MM, Chenn A. 2007. Persistent expression of stabilized beta-catenin delays maturation of radial glial cells into intermediate progenitors. Dev Biol 309:285-297. http://dx.doi.org/10.1016/j.ydbio.2007.07.013.
56. Wathelet MG, Clauss IM, Content J, Huez GA. 1988. Regulation of two interferon-inducible human genes by interferon, poly(rI).poly(rC) and viruses. Eur J Biochem 174:323-329. http://dx.doi.org/10.1111/j.1432-1033.1988.tb14101.x.
57. Pan JQ, Lewis MC, Ketterman JK, Clore EL, Riley M, Richards KR, Berry-Scott E, Liu X, Wagner FF, Holson EB, Neve RL, Biechele TL, Moon RT, Scolnick EM, Petryshen TL, Haggarty SJ. 2011. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36:1397-1411. http://dx.doi.org/10.1038/npp.2011.24.
58. Schroeder JH, Bell LS, Janas ML, Turner M. 2013. Pharmacological inhibition of glycogen synthase kinase 3 regulates T cell development in vitro. PLoS One 8:e58501. http://dx.doi.org/10.1371/journal.pone.0058501.
59. Sun M, Meares G, Song L, Jope RS. 2009. XIAP associates with GSK3 and inhibits the promotion of intrinsic apoptotic signaling by GSK3. Cell Signal 21:1857-1865. http://dx.doi.org/10.1016/j.cellsig.2009.08.002.
60. Wang R, Wang Y, Liu N, Ren C, Jiang C, Zhang K, Yu S, Chen Y, Tang H, Deng Q, Fu C, Wang Y, Li R, Liu M, Pan W, Wang P. 2013. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation. Cell Res 23:803-819. http://dx.doi.org/10.1038/cr.2013.42.
61. Sumi T, Oki S, Kitajima K, Meno C. 2013. Epiblast ground state is controlled by canonical Wnt/beta-catenin signaling in the postimplantation mouse embryo and epiblast stem cells. PLoS One 8:e63378. http://dx.doi.org/10.1371/journal.pone.0063378.
62. Chen L, Salinas GD, Li X. 2009. Regulation of serotonin 1B receptor by glycogen synthase kinase-3. Mol Pharmacol 76:1150-1161. http://dx.doi.org/10.1124/mol.109.056994.
63. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, Vijayakumar S, Economides AN, Aaronson SA. 2010. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24:2517-2530. http://dx.doi.org/10.1101/gad.1957710.
64. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H. 2008. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development 135:2969-2979. http://dx.doi.org/10.1242/dev.021121.
65. Ford E, Thanos D. 2010. The transcriptional code of human IFN-beta gene expression. Biochim Biophys Acta 1799:328-336. http://dx.doi.org/10.1016/j.bbagrm.2010.01.010.
66. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548. http://dx.doi.org/10.1016/S1074-7613(00)00053-4.
67. Clément JF, Bibeau-Poirier A, Gravel SP, Grandvaux N, Bonneil E, Thibault P, Meloche S, Servant MJ. 2008. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol 82:3984-3996. http://dx.doi.org/10.1128/JVI.02526-07.
68. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC. 2004. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11:1060-1067. http://dx.doi.org/10.1038/nsmb847.
69. Noyce RS, Collins SE, Mossman KL. 2009. Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 83:4013-4022. http://dx.doi.org/10.1128/JVI.02069-08.
70. Hadjihannas MV, Bruckner M, Behrens J. 2010. Conductin/axin2 and Wnt signalling regulates centrosome cohesion. EMBO Rep 11:317-324. http://dx.doi.org/10.1038/embor.2010.23.
71. Huang P, Senga T, Hamaguchi M. 2007. A novel role of phospho-betacatenin in microtubule regrowth at centrosome. Oncogene 26:4357-4371. http://dx.doi.org/10.1038/sj.onc.1210217.
72. Faux MC, Coates JL, Kershaw NJ, Layton MJ, Burgess AW. 2010. Independent interactions of phosphorylated beta-catenin with Ecadherin at cell-cell contacts and APC at cell protrusions. PLoS One 5:e14127. http://dx.doi.org/10.1371/journal.pone.0014127.
73. Chilov D, Sinjushina N, Rita H, Taketo MM, Makela TP, Partanen J. 2011. Phosphorylated beta-catenin localizes to centrosomes of neuronal progenitors and is required for cell polarity and neurogenesis in developing midbrain. Dev Biol 357:259-268. http://dx.doi.org/10.1016/j.ydbio.2011.06.029.
74. Tapia M, Del Puerto A, Puime A, Sanchez-Ponce D, Fronzaroli-Molinieres L, Pallas-Bazarra N, Carlier E, Giraud P, Debanne D, Wandosell F, Garrido JJ. 2013. GSK3 and beta-catenin determines [sic] functional expression of sodium channels at the axon initial segment. Cell Mol Life Sci 70:105-120. http://dx.doi.org/10.1007/s00018-012-1059-5.
75. Yuan J, Zhang J, Wong BW, Si X, Wong J, Yang D, Luo H. 2005. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin. Cell Death Differ 12:1097-1106. http://dx.doi.org/10.1038/sj.cdd.4401652.
76. Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S. 1999. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73:578-586.
77. Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, Chen Y, Woodgett JR, Li M. 2010. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J Biol Chem 285:41122-41134. http://dx.doi.org/10.1074/jbc.M110.130351.
78. Hernández F, Langa E, Cuadros R, Avila J, Villanueva N. 2010. Regulation of GSK3 isoforms by phosphatases PP1 and PP2A. Mol Cell Biochem 344:211-215. http://dx.doi.org/10.1007/s11010-010-0544-0.
79. Long L, Deng Y, Yao F, Guan D, Feng Y, Jiang H, Li X, Hu P, Lu X, Wang H, Li J, Gao X, Xie D. 2014. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 40:515-529. http://dx.doi.org/10.1016/j.immuni.2014.01.015.
80. Gu M, Zhang T, Lin W, Liu Z, Wang X. 2014. Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage. Cell Signal 26:2930-2939. http://dx.doi.org/10.1016/j.cellsig.2014.09.007.
81. Park CY, Choi SH, Kang SM, Kang JI, Ahn BY, Kim H, Jung G, Choi KY, Hwang SB. 2009. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 51:853-864. http://dx.doi.org/10.1016/j.jhep.2009.06.026.
82. Street A, Macdonald A, McCormick C, Harris M. 2005. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-cateninresponsive transcription. J Virol 79:5006-5016. http://dx.doi.org/10.1128/JVI.79.8.5006-5016.2005.
83. Srisuttee R, Koh SS, Kim SJ, Malilas W, Boonying W, Cho IR, Jhun BH, Ito M, Horio Y, Seto E, Oh S, Chung YH. 2012. Hepatitis B virus X (HBX) protein upregulates beta-catenin in a human hepatic cell line by sequestering SIRT1 deacetylase. Oncol Rep 28:276-282.
84. Everly DN, Jr, Kusano S, Raab-Traub N. 2004. Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells. J Virol 78:11648-11655. http://dx.doi.org/10.1128/JVI.78.21.11648-11655.2004.
85. Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS, Hayward SD. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 9:300-306. http://dx.doi.org/10.1038/nm829.